Jpmorgan Chase & CO Balchem Corp Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Balchem Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 451,265 shares of BCPC stock, worth $77.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
451,265
Previous 480,356
6.06%
Holding current value
$77.8 Million
Previous $74.4 Million
6.66%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding BCPC
# of Institutions
356Shares Held
29.2MCall Options Held
89.7KPut Options Held
100-
Black Rock Inc. New York, NY4.9MShares$846 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.91MShares$675 Million0.01% of portfolio
-
Apg Asset Management N.V. Amsterdam, P73.01MShares$518 Million0.78% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.68MShares$289 Million1.39% of portfolio
-
State Street Corp Boston, MA1.22MShares$211 Million0.01% of portfolio
About BALCHEM CORP
- Ticker BCPC
- Exchange NASDAQ
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 32,120,600
- Market Cap $5.54B
- Description
- Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal N...